Report overview
The global Afutuzumab market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
Afutuzumab, more commonly known as obinutuzumab is a humanized type II monoclonal antibody against CD20 (coded for by MS4A1 for the treatment of Chronic lymphocytic leukemia, CLL. It may have more direct antibody-dependent cell-mediated cytotoxicity and possibly more direct cytotoxicity than previously available type I antibodies such as rituximab and ofatumumab which have more complement-dependent cytotoxicity.
The U.S. market size is estimated at $ million in 2024, while China is to reach $ million.
Patent segment will reach $ million by 2032, with a % CAGR in next six years.
The global key manufacturers of Afutuzumab include BOC Sciences, Carbosynth, Roche Group, TargetMol Chemicals, Wonda Science, Absin Bioscience, Chunchuang (Wuhan) Technology, Hubei Kele Fine Chemical, Jiangxi Ruiweier Biotechnology, Qingdao Jieshikang Biotechnology, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Afutuzumab manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Afutuzumab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Afutuzumab. This report contains market size and forecasts of Afutuzumab in global, including the following market information:
Global Afutuzumab market revenue, 2020-2025, 2026-2032, ($ millions)
Global Afutuzumab market sales, 2020-2025, 2026-2032, (Kg)
Global top five Afutuzumab companies in 2024 (%)
Total Market by Segment:
Global Afutuzumab market, by Type, 2020-2025, 2026-2032 ($ millions) & (Kg)
Global Afutuzumab market segment percentages, by Type, 2024 (%)
Patent
Generic
Global Afutuzumab market, by Application, 2020-2025, 2026-2032 ($ Millions) & (Kg)
Global Afutuzumab market segment percentages, by Application, 2024 (%)
Chronic Lymphocytic Leukemia
Follicular Lymphoma
Global Afutuzumab market, by region and country, 2020-2025, 2026-2032 ($ millions) & (Kg)
Global Afutuzumab market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Afutuzumab revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Afutuzumab revenues share in global market, 2024 (%)
Key companies Afutuzumab sales in global market, 2020-2025 (estimated), (Kg)
Key companies Afutuzumab sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
BOC Sciences
Carbosynth
Roche Group
TargetMol Chemicals
Wonda Science
Absin Bioscience
Chunchuang (Wuhan) Technology
Hubei Kele Fine Chemical
Jiangxi Ruiweier Biotechnology
Qingdao Jieshikang Biotechnology
Shanghai Biochempartner
Shanghai Macklin Biochemical
Shanghai Qiming Biotechnology
Shanghai Saimai Biotechnology
Shanghai Shize Biological Technology
Shanghai Yifei Biotechnology
Shanghai Yu'ang Chemical
Tianmen Hengchang Chemical
Wuhan Sunrise Technology Development
Wuhan Yingnuo Pharmaceutical Technology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Afutuzumab, market overview.
Chapter 2: Global Afutuzumab market size in revenue and volume.
Chapter 3: Detailed analysis of Afutuzumab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Afutuzumab in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Afutuzumab capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
